Clinical Trials
6 trialsNCT07467629 2026-05-19
QLS5212 for Participants With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT07584954 2026-05-13
Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors
ImmunoUrchin
Phase 1 Recruiting
NCT07441174 2026-02-27
IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors
InxMed (Shanghai) Co., Ltd.
Phase 1/2 Recruiting
NCT07117461 2025-10-16
A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT07146672 2025-08-28
Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors
Shanghai Cell Therapy Group Co.,Ltd
Phase 1/2 Recruiting
NCT06962254 2025-05-08
Imatinib and Trametinib for KRAS-mutated Solid Tumor
China Medical University Hospital
Phase 1 Recruiting